Catheter ablation for atrial fibrillation

Samer Al Said*, Pankaj Garg, Sam Jenkins, Mahmood Ahmad, Mohammed Qintar, Andreas Kyriacou, Nishant Verma, Rui Providencia, John Camm, Samer Alabed

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the efficacy and safety of any catheter ablation in people with first diagnosed, paroxysmal, persistent, and long-standing persistent atrial fibrillation versus any medical therapy.

Original languageEnglish (US)
Article numberCD014810
JournalCochrane Database of Systematic Reviews
Volume2022
Issue number1
DOIs
StatePublished - Jan 9 2022

Funding

We would like to acknowledge the substantial and generous contributions made by Cochrane Heart's Managing Editor (Nicole Martin, University College London, UK); Systematic Review Specialist (Andrea Takeda, University College London, UK); Information Specialist (Charlene Bridges, University College London, UK); and Contact Editor (Sergio Barra, Department of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK, Department of Cardiology, Hospital da Luz Arrábida, Vila Nova de Gaia, Portugal). We thank Caleb Ferguson (Western Sydney University) and an additional peer reviewer who wishes to remain anonymous, who helped to inform the Background and Methods of the review at the protocol stage. This project was supported by the NIHR via Cochrane Infrastructure funding to the Heart Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health and Social Care.

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Catheter ablation for atrial fibrillation'. Together they form a unique fingerprint.

Cite this